SynthesisJournal for immunotherapy of cancer2021

Type I T cells sensitize treatment refractory tumors to chemotherapy through inhibition of oncogenic signaling pathways.

Denise Cecil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.